Methods of administering immunoconjugates that bind to CD123 are provided. The methods comprise administering an anti-CD123 immunoconjugate (e.g., IMGN632) to a subject in need thereof, for example, a patient with a hematologic malignancy, at a therapeutically effective dose regimen that results in treatment of the hematologic malignancy.
展开▼